Center for Environmentally Beneficial Catalysis
  • Home
  • Industry Partners
  • Industry

colorful flasksMembership
Industry members gain a competitive edge by partnering with CEBC. Learn about how your company can become a member.

 

researcher in labContract R&D
Several opportunities exist for confidential research at CEBC, including sponsored proprietary projects, testing services and on-campus lab space.  Learn how to get the most out of our R&D resources.

 

light bulbIndustry Advisory Board
Dedicated individual representatives from member companies make up our Industry Advisory Board (IAB). See a list of current and former board members.

 

Student with reactorSemi-Annual Advisory Board Meetings
Industry and Scientific Advisory Board members meet regularly with CEBC researchers to exchange ideas and evaluate projects. Meeting information and registration.

 

light bulbIntellectual Property
The innovations developed at CEBC are part of a growing patent portfolio. More than 23 patents and patent applications are available to industry for licensing opportunities.

 


CEBC Calendar

September 1, Tuesday - CEBC Colloquium / NRT Seminar Series
9:00 a.m., via Zoom
Tessa Rhinehart, University of Pittsburgh programmer uniting math, biology, and artificial intelligence to study ecosystems
"Listening to a Landscape: Perspectives on big data in the field of bioacoustics"

September 15, Tuesday - CEBC Colloquium / NRT Seminar Series
9:00 a.m., via Zoom
Arely Torres, LyondellBasell, Research Engineer
"Navigating Career Pathways"

October 6, Tuesday - CEBC Colloquium / NRT Seminar Series
9:00 a.m., via Zoom
Milind Kantak, INVISTA, Intellectual Property Manager and Chemical Engineer
"Intellectual Property and Industry Perspective"

October 14, Wednesday - Mandatory Safety Meeting 
9:00 a.m., via Zoom
Presenter: Kirk Snavely, Topic: TBA
This meeting is mandatory for all CEBC researchers working at 1501 Wakarusa

 

KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding